Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172


Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Dewland TA, Soliman EZ, Yamal JM, Davis BR, Alonso A, Albert CM, Simpson LM, Haywood LJ, Marcus GM.

Circ Arrhythm Electrophysiol. 2017 Dec;10(12). pii: e005463. doi: 10.1161/CIRCEP.117.005463.


Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT.

Haywood LJ, Davis BR, Piller LB, Cushman WC, Cutler JA, Ford CE, Simpson LM, Ghosh A, Soliman EZ, Wright JT Jr; ALLHAT Collaborative Research Group.

J Natl Med Assoc. 2017 Autumn;109(3):172-181. doi: 10.1016/j.jnma.2017.02.005. Epub 2017 Mar 18.


Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).

Appleton JP, Scutt P, Dixon M, Howard H, Haywood L, Havard D, Hepburn T, England T, Sprigg N, Woodhouse LJ, Wardlaw JM, Montgomery AA, Pocock S, Bath PM; RIGHT-2 Investigators.

Int J Stroke. 2017 Jan 1:1747493017724627. doi: 10.1177/1747493017724627. [Epub ahead of print]


Gestation length and racing performance in 115 Thoroughbred foals with incomplete tarsal ossification.

Haywood L, Spike-Pierce DL, Barr B, Mathys D, Mollenkopf D.

Equine Vet J. 2018 Jan;50(1):29-33. doi: 10.1111/evj.12712. Epub 2017 Jul 20.


Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.

Sarper M, Allen MD, Gomm J, Haywood L, Decock J, Thirkettle S, Ustaoglu A, Sarker SJ, Marshall J, Edwards DR, Jones JL.

Breast Cancer Res. 2017 Mar 23;19(1):33. doi: 10.1186/s13058-017-0822-9.


Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease.

Dewland TA, Soliman EZ, Davis BR, Magnani JW, Yamal JM, Piller LB, Haywood LJ, Alonso A, Albert CM, Marcus GM; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group.

JAMA Intern Med. 2016 Aug 1;176(8):1085-92. doi: 10.1001/jamainternmed.2016.2502.


The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis.

Clarke CJ, Berg TJ, Birch J, Ennis D, Mitchell L, Cloix C, Campbell A, Sumpton D, Nixon C, Campbell K, Bridgeman VL, Vermeulen PB, Foo S, Kostaras E, Jones JL, Haywood L, Pulleine E, Yin H, Strathdee D, Sansom O, Blyth K, McNeish I, Zanivan S, Reynolds AR, Norman JC.

Curr Biol. 2016 Mar 21;26(6):755-65. doi: 10.1016/j.cub.2016.01.045. Epub 2016 Mar 3.


Genetic testing in a cohort of young patients with HER2-amplified breast cancer.

Eccles DM, Li N, Handwerker R, Maishman T, Copson ER, Durcan LT, Gerty SM, Jones L, Evans DG, Haywood L, Campbell I.

Ann Oncol. 2016 Mar;27(3):467-73. doi: 10.1093/annonc/mdv592. Epub 2015 Dec 17.


Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).

Alderman MH, Davis BR, Piller LB, Ford CE, Baraniuk MS, Pressel SL, Assadi MA, Einhorn PT, Haywood LJ, Ilamathi E, Oparil S, Retta TM; ALLHAT Collaborative Research Group.

Am J Cardiol. 2016 Jan 1;117(1):105-15. doi: 10.1016/j.amjcard.2015.10.012. Epub 2015 Oct 19.


Abnormal Origin of the Right Pulmonary Artery From Ascending Aorta (Hemitruncus Arteriosus).

Haywood LJ, Chakryan Y, Kim D, Boltzer T, Rivas G, Shavelle D.

J Investig Med High Impact Case Rep. 2014 Jul 27;2(3):2324709614536139. doi: 10.1177/2324709614536139. eCollection 2014 Jul-Sep.


Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.

Oparil S, Davis BR, Cushman WC, Ford CE, Furberg CD, Habib GB, Haywood LJ, Margolis K, Probstfield JL, Whelton PK, Wright JT Jr; ALLHAT Collaborative Research Group.

Hypertension. 2013 May;61(5):977-86. doi: 10.1161/HYPERTENSIONAHA.111.00213. Epub 2013 Mar 25.


Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Rahman M, Ford CE, Cutler JA, Davis BR, Piller LB, Whelton PK, Wright JT Jr, Barzilay JI, Brown CD, Colon PJ Sr, Fine LJ, Grimm RH Jr, Gupta AK, Baimbridge C, Haywood LJ, Henriquez MA, Ilamaythi E, Oparil S, Preston R; ALLHAT Collaborative Research Group.

Clin J Am Soc Nephrol. 2012 Jun;7(6):989-1002. doi: 10.2215/CJN.07800811. Epub 2012 Apr 5.


Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Cushman WC, Davis BR, Pressel SL, Cutler JA, Einhorn PT, Ford CE, Oparil S, Probstfield JL, Whelton PK, Wright JT Jr, Alderman MH, Basile JN, Black HR, Grimm RH Jr, Hamilton BP, Haywood LJ, Ong ST, Piller LB, Simpson LM, Stanford C, Weiss RJ; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):20-31. doi: 10.1111/j.1751-7176.2011.00568.x. Epub 2011 Dec 9.


Racial/ethnic differences in the prevalence of atrial fibrillation among older adults--a cross-sectional study.

Haywood LJ.

J Natl Med Assoc. 2011 Feb;103(2):180-1. No abstract available.


Maintaining control is team's vital role.

Haywood L, Frankel C, Johns A; IFHE.

Health Estate. 2011 Feb;65(2):29-32.


Serious ups and downs.

Chen SF, Yabumoto K, Haywood LJ.

Am J Med. 2010 Dec;123(12):1094-6. doi: 10.1016/j.amjmed.2010.07.003. Epub 2010 Oct 15. No abstract available.


Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A; ALLHAT Collaborative Research Group.

J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31. doi: 10.1016/j.jacc.2009.08.020.


Local media influence on opting out from an exception from informed consent trial.

Nelson MJ, DeIorio NM, Schmidt T, Griffiths D, Daya M, Haywood L, Zive D, Newgard CD.

Ann Emerg Med. 2010 Jan;55(1):1-8. doi: 10.1016/j.annemergmed.2009.05.028. Epub 2009 Aug 13.


ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

Wright JT Jr, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, Einhorn PT, Rahman M, Whelton PK, Ford CE, Haywood LJ, Margolis KL, Oparil S, Black HR, Alderman MH; ALLHAT Collaborative Research Group.

Arch Intern Med. 2009 May 11;169(9):832-42. doi: 10.1001/archinternmed.2009.60.


Cardiovascular function and dysfunction in sickle cell anemia.

Haywood LJ.

J Natl Med Assoc. 2009 Jan;101(1):24-30. Review.


Clinical assessment of the risk for sudden cardiac death in patients with sickle cell anemia.

Fontaine JM, Ofili EO, Adenaike MB, VanDecker W, Haywood LJ.

J Natl Med Assoc. 2008 Apr;100(4):360-8.


Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

Arch Intern Med. 2008 Jan 28;168(2):207-17. doi: 10.1001/archinternmed.2007.66.


Acute myocardial infarction with normal coronary arteries in a patient with Hodgkin's disease.

Haywood LJ.

Tex Heart Inst J. 2007;34(1):135. No abstract available.


Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2006 Sep;48(3):374-84. Epub 2006 Jul 24.


Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial.

Bush D, Martin LW, Leman R, Chandler M, Haywood LJ; NHLBI AFFIRM Investigators.

J Natl Med Assoc. 2006 Mar;98(3):330-9.


Left bundle branch block in acute myocardial infarction: benign or malignant?

Haywood LJ.

J Am Coll Cardiol. 2005 Jul 5;46(1):39-41. No abstract available. Erratum in: J Am Coll Cardiol. 2005 Sep 6;46(5):936.


Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL; National Heart, Lung, and Blood Institute AFFIRM Investigators.

Arch Intern Med. 2005 May 23;165(10):1185-91.


Ventricular diastolic function study has shortcomings.

Haywood LJ.

J Natl Med Assoc. 2005 Apr;97(4):583. No abstract available.


Bone marrow embolism in sickle cell disease: a review.

Dang NC, Johnson C, Eslami-Farsani M, Haywood LJ.

Am J Hematol. 2005 May;79(1):61-7. Review.


Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB; ALLHAT Collaborative Research Group.

JAMA. 2005 Apr 6;293(13):1595-608.


Atrial fibrillation in a multiethnic inpatient population of a large public hospital.

Dang D, Patel R, Haywood LJ.

J Natl Med Assoc. 2004 Nov;96(11):1438-44.


Combined effect of bradykinin B2 and neurokinin-1 receptor activation on endothelial cell proliferation in acute synovitis.

Seegers HC, Avery PS, McWilliams DF, Haywood L, Walsh DA.

FASEB J. 2004 Apr;18(6):762-4. Epub 2004 Feb 6.


Inflammation and angiogenesis in osteoarthritis.

Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D, Walsh DA.

Arthritis Rheum. 2003 Aug;48(8):2173-7.


A review of atrial fibrillation.

Dang D, Arimie R, Haywood LJ.

J Natl Med Assoc. 2002 Dec;94(12):1036-48. Review.


Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.

Carty SE, Roberts MM, Virji MA, Haywood L, Yim JH.

Surgery. 2002 Dec;132(6):1086-92; discussion 1092-3.


Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.

Piller LB, Davis BR, Cutler JA, Cushman WC, Wright JT Jr, Williamson JD, Leenen FH, Einhorn PT, Randall OS, Golden JS, Haywood LJ; The ALLHAT Collaborative Research Group .

Curr Control Trials Cardiovasc Med. 2002 Nov 14;3(1):10.


Angiogenesis: a therapeutic target in arthritis.

Walsh DA, Haywood L.

Curr Opin Investig Drugs. 2001 Aug;2(8):1054-63. Review.


Ethical relationships in paediatric emergency medicine: moving beyond the dyad.

Bridges J, Hanson R, Little M, Flannigan AC, Fairley M, Haywood L.

Emerg Med (Fremantle). 2001 Sep;13(3):344-50. Review.


Access to Care for Elderly Persons.

Haywood LJ.

Am J Geriatr Cardiol. 1997 Nov;6(6):32-37.


Vasculature of the normal and arthritic synovial joint.

Haywood L, Walsh DA.

Histol Histopathol. 2001 Jan;16(1):277-84. Review.


Early efforts of blacks in the fight against heart disease and stroke.

Haywood LJ.

J Natl Med Assoc. 1999 Dec;91(12):669-75.


Social class and recovery from myocardial infarction.

Haywood LJ.

Ann Intern Med. 1998 Apr 15;128(8):695-6. No abstract available.


Predictive value of prior Rose angina for myocardial infarction confirmation after emergency admissions.

Haywood LJ, Faucett C, deGuzman M, Ell K, Norris S, Butts E.

J Natl Med Assoc. 1998 Apr;90(4):241-52. Erratum in: J Natl Med Assoc 1998 Aug;90(8):453.


Tumor necrosis factor alpha.

Haywood LJ.

J Natl Med Assoc. 1998 Mar;90(3):129. No abstract available.


Early radionuclide scans for risk assessment in suspected acute myocardial infarction.

Norris SL, Haywood LJ, Sobel E, Hung GL, deGuzman M, Siegel M.

J Natl Med Assoc. 1997 Dec;89(12):791-800.


Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma.

Sharkey RM, Blumenthal RD, Behr TM, Wong GY, Haywood L, Forman D, Griffiths GL, Goldenberg DM.

Int J Cancer. 1997 Jul 29;72(3):477-85.


Application of cytokine intervention for improved radio-antibody dose delivery.

Blumenthal RD, Sharkey RM, Haywood L, Behr T, Goldenberg DM.

Int J Cancer. 1997 Jul 3;72(1):166-73.


Recurrent myocardial infarction with patent coronary arteries.

Haywood LJ, Khan AH, Bornheimer J, Finck E, Tatter D.

J Natl Med Assoc. 1997 Jun;89(6):415-20. Review.


The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction.

Toth K, Bogar L, Juricskay I, Keltai M, Yusuf S, Haywood LJ, Meiselman HJ.

Clin Hemorheol Microcirc. 1997 Mar-Apr;17(2):117-25.


Supplemental Content

Loading ...
Support Center